Tamer Rezk
Overview
Explore the profile of Tamer Rezk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Razvi Y, Porcari A, Di Nora C, Patel R, Ioannou A, Rauf M, et al.
Front Cardiovasc Med
. 2023 Feb;
9:1075806.
PMID: 36741843
Aims: Transthyretin cardiac amyloidosis (ATTR-CM) is a progressive and fatal cardiomyopathy. Treatment options in patients with advanced ATTR-CM are limited to cardiac transplantation (CT). Despite case series demonstrating comparable outcomes...
2.
Somers H, Tanzim U, Porcari A, Razvi Y, Rezk T, Patel R, et al.
JACC Cardiovasc Imaging
. 2022 Jul;
15(7):1353-1355.
PMID: 35798411
No abstract available.
3.
Rezk T, Salota R, Gan J, Lachmann H, Fontana M, Siew K, et al.
Br J Haematol
. 2021 Aug;
194(6):1016-1023.
PMID: 34374069
Renal risk stratification in systemic immunoglobulin light-chain (AL) amyloidosis is according to estimated glomerular filtration rate (eGFR) and urinary protein creatinine ratio (uPCR), the latter attributed to glomerular dysfunction, with...
4.
Chacko L, Boldrini M, Martone R, Law S, Martinez-Naharrro A, Hutt D, et al.
Circ Cardiovasc Imaging
. 2021 Apr;
:CIRCIMAGING121012506.
PMID: 33876651
Background: Systemic amyloidosis is characterized by amyloid deposition that can involve virtually any organ. Splenic and hepatic amyloidosis occurs in certain types, in some patients but not others, and may...
5.
Law S, Cohen O, Lachmann H, Rezk T, Gilbertson J, Rowczenio D, et al.
Nephrol Dial Transplant
. 2021 Jan;
36(2):355-365.
PMID: 33439995
Background: Outcomes after renal transplantation have traditionally been poor in systemic amyloid A (AA) amyloidosis and systemic light chain (AL) amyloidosis, with high mortality and frequent recurrent disease. We sought...
6.
Papa R, Lane T, Minden K, Touitou I, Cantarini L, Cattalini M, et al.
J Allergy Clin Immunol Pract
. 2020 Nov;
9(2):783-791.e4.
PMID: 33181346
Background: TNF receptor-associated periodic syndrome (TRAPS) is a rare autoinflammatory disease caused by dominant mutation of the TNF super family receptor 1A (TNFRSF1A) gene. Data regarding long-term treatment outcomes are...
7.
Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T, et al.
JACC Cardiovasc Imaging
. 2020 May;
13(5):1294-1295.
PMID: 32381249
No abstract available.
8.
Chacko L, Martone R, Bandera F, Lane T, Martinez-Naharro A, Boldrini M, et al.
Eur Heart J
. 2020 Jan;
41(14):1439-1447.
PMID: 31950987
Aims: Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is an increasingly recognized cause of heart failure. We sought to characterize the structural and functional echocardiographic phenotype across the spectrum of wild-type (wtATTR-CM) and...
9.
Rowczenio D, Youngstein T, Trojer H, Omoyinmi E, Baginska A, Brogan P, et al.
Rheumatology (Oxford)
. 2019 Aug;
59(3):554-558.
PMID: 31384939
Objectives: Hereditary systemic autoinflammatory diseases are rare genetic disorders, which if untreated, can be complicated by AA amyloidosis leading to renal failure and premature death. Our objective was to find...
10.
Taylor G, Gilbertson J, Sayed R, Blanco A, Rendell N, Rowczenio D, et al.
Kidney Int Rep
. 2019 Jul;
4(7):977-986.
PMID: 31317119
Introduction: Hereditary fibrinogen Aα-chain (AFib) amyloidosis is a relatively uncommon renal disease associated with a small number of pathogenic fibrinogen Aα (FibA) variants; wild-type FibA normally does not result in...